1De Paoli A, Buonadonna A, Boz G, et al. Combined modality treatment for locally advanced gastric cancer. Suppl Tumori, 2003,2 :S.58-62.
2Kelsen DP. Adjuvant and neoadjuvant therapy for gastric cancer.Semin Oncol, 1996, 23:379-389.
3Hermans J, Bonenkamp JJ, Boon MC, et al. Adjuvant therapy aftercurative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol, 1993, 11 : 1441-1447.
4Kasakura Y, Phan A, Ajani J. Adjuvant therapy for resected gastric carcinoma. Surg Oncol Clin N Am, 2002, 11:431444, xii-xiii.
5Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med, 2001, 345:725-730.
6Cascinu S, Graziano F, Del Ferro E, et al. Expression of p53 protein and resistance to preoperative chemotherapy in locally advanced gastric carcinoma. Cancer, 1998, 83:1917-1922.
7Frei E 3rd. Clinical cancer research:an embattled species. Cancer,1982, 50 : 1979-1992.
8Fink U, Stein HJ, Schuhmacher C, et al. Neoadjuvant chemotherapy for gastric cancer: update. World J Surg, 1995, 19:509-516.
9Niederhuber JE. Neoadjuvant therapy. Ann Surg, 1999, 229 : 309-312.
10Fujii M, Kochi M, Mochizuki F. Significance of neoadjuvant chemotherapy for gastric cancer. Gan To Kagaku Ryoho, 2000, 27 :2028 -2032.
